Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study
Authors:
- Massimo ZucchettiMZMassimo Zucchetti
- Renzo BagnatiRBRenzo Bagnati
- Maurizio D’incalciMDMaurizio D’incalci
- Silvia PaceSPSilvia Pace
- Francesca CapocasaFCFrancesca Capocasa
- Elena MarangonEMElena Marangon
- 1 October 2009
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 877 (27) , 3118-3126
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activityMolecular Cancer Therapeutics, 2008
- A rapid, sensitive and selective liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry method for determination of fenretinide (4-HPR) in plasmaJournal of Chromatography B, 2008
- Development and validation of a LC–MS/MS method for the determination of viaminate in human plasmaJournal of Chromatography B, 2007
- Antitumor activity of the combination of synthetic retinoid ST1926 and cisplatin in ovarian carcinoma modelsAnnals of Oncology, 2007
- Quantitative high‐throughput determination of endogenous retinoids in human plasma using triple‐stage liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2007
- Development of Resistance to the Atypical Retinoid, ST1926, in the Lung Carcinoma Cell Line H460 Is Associated with Reduced Formation of DNA Strand Breaks and a Defective DNA Damage ResponseNeoplasia, 2005
- Cellular and Pharmacological Bases of the Antitumor Activity of a Novel Adamantyl Retinoid, ST1926Journal of Chemotherapy, 2004
- Retinoid Related Molecules an Emerging Class of Apoptotic Agents with Promising Therapeutic Potential in Oncology: Pharmacological Activity and Mechanisms of ActionCurrent Pharmaceutical Design, 2004
- Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoidCell Death & Differentiation, 2003
- A Novel Atypical Retinoid Endowed with Proapoptotic and Antitumor ActivityJournal of Medicinal Chemistry, 2003